A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice

Fertility and Sterility

Volumn 86, Issue 4 SUPPL., 2006, Pages 1146-1151

  Ozawa, Yuka ^a   Murakami, Takashi ^a   Tamura, Mitsutoshi ^a   Terada, Yukihiro ^a   Yaegashi, Nobuo ^a   Okamura, Kunihiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cox 2; Cyclooxygenase 2; endometriosis; selective cyclooxygenase 2 inhibitor; xenograft model

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DRUG VEHICLE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL LABELING; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ENDOMETRIUM TUMOR; EVALUATION; EXPLANT; FEMALE; GRADUATE; IMMUNOHISTOCHEMISTRY; JAPAN; MEASUREMENT; MEDICAL SCHOOL; MICROVASCULATURE; MOUSE; NONHUMAN; OVARY TUMOR; PERITONEUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCID MOUSE; STROMA CELL; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR CELL; TUMOR VOLUME; TUMOR XENOGRAFT;

ADULT; ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; BLOOD VESSELS; CELL PROLIFERATION; CYCLOOXYGENASE 2 INHIBITORS; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC TECHNIQUES; MICE; MICE, SCID; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITROBENZENES; PERITONEUM; STAINING AND LABELING; SULFONAMIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 33748908988     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.01.057     Document Type: Article

References (36)

1. ACOG practice bulletin. Medical management of endometriosis number 11, December 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynecol Obstet 71 (2000) 183-196
2. Tortora G., Caputo R., Damiano V., Melisi D., Bianco R., Fontanini G., et al. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. Clin Cancer Res 9 (2003) 1566-1572
3. Tsujii M., and DuBois R.N. Alternation in cellular adhesion and apoptosis in epithelial cells oberexpressing prostaglandin endoperoxidase synthase 2. Cell 83 (1995) 493-501
4. Subbaramaiah K., and Dannenberg A.L. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24 (2003) 95-102
5. Kakizoe T. Chemoprevention of cancer-focusing on clinical trials. Jpn J Clin Oncol 33 (2003) 421-442
6. Ota H., Igarashi S., Sasaki M., and Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16 (2001) 561-566
7. Chishima F., Hayakawa S., Sugita K., Kinukawa N., Aleemuzzaman S., Nemoto N., et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 48 (2002) 50-56
8. Fagotti A., Ferrandina G., Fanfani F., Legge F., Lauriola L., Gessi M., et al. Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters. Hum Reprod 19 (2004) 393-397
9. Jimbo H., Hitomi Y., Yoshikawa H., Yano T., Momoeda M., Sakamoto A., et al. Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am J Pathol 150 (1997) 1173-1178
10. Tamura M., Hukaya T., Murakami T., Uehara S., and Yajima A. Analysis of clonality in human endometriotic cysts based on evaluation of X chromosome inactivation in archival formalin-fixed, paraffin-embedded tissue. Lab Invest 78 (1998) 213-218
11. Sawaoka H., Kuwano S., Tsuji S., Tsujii M., Gunawan E.S., Takei Y., et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274 (1998) G1061-G1067
12. Maesfferrer J.L., Zweifel B.S., Mannig P.T., Hauser S.D., Leathy K.M., Walter G.M., et al. Selective inhibition of inducible cyclooxygenase in vivo is antiinflammatory and nonulcergenic. Proc Natl Acad Sci USA 91 (1994) 322-332
13. Futaki N., Yoshikawa K., Hamasaka Y., Arai I., Higuchi S., Iizuka H., et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 24 (1993) 105-110
14. Matsuura-Sawada R., Murakami T., Ozawa Y., Nabeshima H., Akahira J., Sato Y., et al. Reproduction of menstrual changes in transplanted human endometrial tissue in immunodeficient mice. Hum Reprod 20 (2005) 1477-1484
15. Naruse I., Keino H., and Kawarada Y. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 101 (1994) 73-78
16. Nap A.W., Griffioen A.W., Dunselman G.A.J., Bouma-ter Steege J.C.A., Thijssen V.L.J.L., Evers J.L.H., et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 89 (2004) 1089-1095
17. Wagatsuma S., Konno R., Sato S., and Yajima A. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82 (1998) 520-530
18. Laoag-Fernandez J.B., Maruo T., Pakarinen P., Spitz I.M., and Johansson E. Effects of levonorgestrel-releasing intra uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis. Hum Reprod 18 (2003) 694-699
19. Nagashio Y., Ueno H., Imamura M., Asaumi H., Watanabe S., Yamaguchi T., et al. Inhibition of transforming growth factor decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Lab Invest 84 (2004) 1610-1618
20. Hull M.L., Charnock-Jones D.S., Chan C.L.K., Bruner-Tran K.L., Osteen K.G., Tom B.D.M., et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88 (2003) 2889-2899
21. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19 (2000) 19-27
22. Yazawa K., Tsuno N.H., Kitayama J., Kawai K., Okaji Y., Asakage M., et al. Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial proliferation by induction of cell cycle arrest. Int J Cancer 113 (2005) 541-548
23. Dogan E., Saygili U., Posaci C., Tuna B., Caliskan S., Altunyurt S., et al. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 82 Suppl 3 (2004) 1115-1120
24. Matsuzaki S., Canis M., Darcha C., Dallel R., Okamura K., and Mage G. Cyclooxynegase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 82 (2004) 1609-1615
25. Redwine D.B. Was Sampson wrong?. Fertil Steril 78 (2002) 686-693
26. Hull M.L., Prentice A., Wang D.Y., Butt R.P., Phillips S.C., Smith S.K., et al. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod 20 (2005) 350-358
27. Greenberg L.H., and Slayden O.D. Human endometriotic xenografts in immunodeficient RAG-2/gamma(c)KO mice. Am J Obstet Gynecol 190 (2004) 1788-1796
28. Aoki D., Katsuki Y., Shimizu A., Kakinuma C., and Nozawa S. Successful heterotransplantation of human endometrium in SCID mice. Obstet Gynecol 83 (1994) 220-228
29. Goteri G., Lucarini G., Filosa A., Pierantoni A., Montik N., Biagini G., et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril 81 (2004) 1528-1533
30. Reding T.V., Bimmler D., Perren A., Sun L.K., Fortunato F., Storni F., et al. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis. Gut (2005) Dec 1.
31. Harada M., Suganuma N., Furuhashi M., Nagasaka T., Nakashima N., Kikkawa F., et al. Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 2 (1996) 307-315
32. Gounenou A.G., Matalliotakis I.M., Tzardi M., Fragouli Y.G., Mahutte N.G., and Arici A. Apoptosis and differential expression of apoptosis-related proteins in endometriotic glandular and stromal cells. J Soc Gynecol Investig 11 (2004) 318-322
33. Noble L.S., Takayama K., Zeitoun K.M., Putman J.M., Johns D.A., Hinshelwood M.M., et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82 (1997) 600-606
34. Bulun S.E., Zaitoun K.M., Takayama K., and Sasano H. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J Mol Endocrinol 25 (2000) 35-42
35. Kurumbail R.G., Stevens A.M., Girse J.K., McDonald J.J., Stegeman R.A., Pak J.Y., et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384 (1996) 644-648
36. Chen W.S., Wei S.J., Liu J.M., Hsiao M., Kou-Lin J., and Yang W.K. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2 selective inhibitor, Etodolac. Int J Cancer 91 (2001) 894-899